Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin

por Ahrén, Bo
Publicado 2008

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin

por Ahrén, Bo
Publicado 2010

Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

por Ahrén, Bo
Publicado 2013

DPP‐4 inhibition and islet function

por Ahrén, Bo
Publicado 2011

Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development

por Ahrén, Bo
Publicado 2018

DPP-4 Inhibition and the Path to Clinical Proof

por Ahrén, Bo
Publicado 2019

Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition

por Ahrén, Bo
Publicado 2021

The Glucose Sensitivity of Insulin Secretion-Lessons from In Vivo and In Vitro Studies in Mice

por Ahrén, Bo
Publicado 2022

Glucose‐dependent insulinotropic polypeptide secretion after oral macronutrient ingestion: The human literature revisited and a systematic study in model experiments in mice

por Ahrén, Bo
Publicado 2022

Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice

por Ahrén, Bo
Publicado 2023

Ischaemic and Metabolic Treatment of Hepatic Tumours

por Ahrén, Bo, Bengmark, Stig
Publicado 1988

Glucagon‐like peptide‐1 and glucose‐dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice

por Pacini, Giovanni, Ahrén, Bo
Publicado 2017

Insulin and incretin hormone responses to rapid versus slow ingestion of a standardized solid breakfast in healthy subjects

por Alsalim, Wathik, Ahrén, Bo
Publicado 2019

Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men

por Lindgren, Ola, Ahrén, Bo
Publicado 2020

Glucose effectiveness: Lessons from studies on insulin‐independent glucose clearance in mice

por Ahrén, Bo, Pacini, Giovanni
Publicado 2020

Disturbed α-Cell Function in Mice with β-Cell Specific Overexpression of Human Islet Amyloid Polypeptide

por Ahrén, Bo, Sörhede Winzell, Maria
Publicado 2008

Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes

por Ahrén, Bo, Foley, James E.
Publicado 2016

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration

por Foley, James E, Ahrén, Bo
Publicado 2017

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

por Tschöp, Matthias, Nogueiras, Ruben, Ahrén, Bo
Publicado 2023

Disassociated relation between plasma tumor necrosis factor-α, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight var...

por Lindgärde, Folke, Gottsäter, Anders, Ahrén, Bo
Publicado 2010